TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

TPEX:4157 Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	8,044	9,539	8,219	10,911	11,505	11,039
Market Cap Growth	-6.62%	16.05%	-24.67%	-5.16%	4.22%	-32.60%
Enterprise Value	7,066	8,758	7,222	10,169	10,545	10,032
Last Close Price	11.30	13.40	11.45	15.20	16.05	15.40
PE Ratio	188.33	211.13	-	79.80	-	14.23
PS Ratio	31.00	36.76	54.56	88.61	317.56	8.53
PB Ratio	7.48	8.87	7.59	9.75	11.86	8.81
P/TBV Ratio	7.64	9.06	7.68	9.87	11.86	8.81
P/FCF Ratio	412.90	489.64	-	3055.51	-	17.84
P/OCF Ratio	384.33	455.76	-	1462.83	-	17.55
EV/Sales Ratio	27.23	33.75	47.94	82.59	291.05	7.75
EV/EBITDA Ratio	81.34	100.82	-	-	-	11.03
EV/EBIT Ratio	101.83	126.21	-	-	-	11.15
EV/FCF Ratio	362.72	449.58	-	2847.73	-	16.21
Debt / Equity Ratio	0.05	0.05	0.05	0.07	0.04	0.04
Debt / EBITDA Ratio	0.57	0.57	-	-	-	0.06
Debt / FCF Ratio	2.53	2.53	-	20.92	-	0.09
Net Debt / Equity Ratio	-0.91	-0.91	-0.89	-0.86	-0.89	-0.69
Net Debt / EBITDA Ratio	-11.25	-11.25	8.45	5.85	3.22	-0.96
Net Debt / FCF Ratio	-50.18	-50.18	5.54	-269.76	34.88	-1.41
Asset Turnover	0.22	0.22	0.13	0.11	0.03	1.33
Inventory Turnover	0.31	0.31	0.42	0.46	0.23	0.78
Quick Ratio	12.51	12.51	22.49	22.38	17.97	13.41
Current Ratio	13.48	13.48	23.57	23.19	18.50	13.71
Return on Equity (ROE)	4.19%	4.19%	-3.51%	13.09%	-21.33%	91.47%
Return on Assets (ROA)	3.71%	3.71%	-6.35%	-9.59%	-14.23%	57.68%
Return on Invested Capital (ROIC)	52.08%	49.94%	-88.22%	-125.41%	-112.72%	311.53%
Return on Capital Employed (ROCE)	6.40%	6.40%	-10.80%	-14.80%	-27.90%	69.00%
Earnings Yield	0.56%	0.47%	-0.47%	1.25%	-2.06%	7.03%
FCF Yield	0.24%	0.20%	-2.11%	0.03%	-0.21%	5.61%
Buyback Yield / Dilution	-4.95%	-4.95%	-0.03%	-0.06%	0.07%	-0.07%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.